Only	O	0,4
a	O	5,6
small	O	7,12
minority	O	13,21
of	O	22,24
facial	B-KP	25,31
palsy	I-KP	32,37
cases	O	38,43
are	O	44,47
bilateral	O	48,57
.	O	57,58

Although	O	59,67
unilateral	O	68,78
facial	B-KP	79,85
palsy	I-KP	86,91
is	O	92,94
commonly	O	95,103
idiopathic	O	104,114
,	O	114,115
the	O	116,119
majority	O	120,128
of	O	129,131
bilateral	O	132,141
facial	B-KP	142,148
palsy	I-KP	149,154
cases	O	155,160
have	O	161,165
an	O	166,168
identifiable	O	169,181
cause	O	182,187
.	O	187,188
[	O	189,190
28	O	190,192
,	O	192,193
29	O	194,196
,	O	196,197
30	O	198,200
,	O	200,201
31	O	202,204
]	O	204,205
The	O	206,209
association	O	210,221
of	O	222,224
bilateral	O	225,234
facial	B-KP	235,241
palsy	I-KP	242,247
and	O	248,251
Lyme	B-KP	252,256
disease	I-KP	257,264
has	O	265,268
been	O	269,273
previously	O	274,284
recognized	O	285,295
.	O	295,296
[	O	297,298
22	O	298,300
,	O	300,301
32	O	302,304
]	O	304,305
In	O	306,308
our	O	309,312
multivariate	O	313,325
analysis	O	326,334
,	O	334,335
bilateral	O	336,345
facial	B-KP	346,352
palsy	I-KP	353,358
was	O	359,362
an	O	363,365
independent	O	366,377
predictor	O	378,387
of	O	388,390
Lyme	B-KP	391,395
disease	I-KP	396,403
.	O	403,404

Because	O	405,412
the	O	413,416
predictor	O	417,426
was	O	427,430
not	O	431,434
validated	O	435,444
by	O	445,447
bootstrap	O	448,457
methods	O	458,465
(	O	466,467
selected	O	467,475
in	O	476,478
less	O	479,483
than	O	484,488
half	O	489,493
of	O	494,496
the	O	497,500
1000	O	501,505
iterations	O	506,516
)	O	516,517
,	O	517,518
we	O	519,521
did	O	522,525
not	O	526,529
include	O	530,537
bilateral	O	538,547
facial	B-KP	548,554
palsy	I-KP	555,560
in	O	561,563
our	O	564,567
final	O	568,573
multivariate	O	574,586
analysis	O	587,595
.	O	595,596

However	O	597,604
,	O	604,605
bilateral	O	606,615
facial	B-KP	616,622
palsy	I-KP	623,628
might	O	629,634
be	O	635,637
selected	O	638,646
as	O	647,649
a	O	650,651
predictor	O	652,661
of	O	662,664
Lyme	B-KP	665,669
disease	I-KP	670,677
facial	B-KP	678,684
palsy	I-KP	685,690
in	O	691,693
a	O	694,695
larger	O	696,702
size	O	703,707
cohort	O	708,714
or	O	715,717
with	O	718,722
an	O	723,725
independent	O	726,737
external	O	738,746
validation	O	747,757
.	O	757,758

Clinicians	O	759,769
treating	O	770,778
patients	O	779,787
with	O	788,792
bilateral	O	793,802
facial	B-KP	803,809
palsy	I-KP	810,815
should	O	816,822
strongly	O	823,831
consider	O	832,840
obtaining	O	841,850
diagnostic	O	851,861
testing	O	862,869
for	O	870,873
Lyme	B-KP	874,878
disease	I-KP	879,886
.	O	886,887

